A national Skin Health campaign launched on March 20, uniting dermatologists, skincare experts, advocacy organizations, industry leaders, and celebrities to raise awareness, promote prevention, and improve access to effective skin care across the United States.
Produced by Mediaplanet in partnership with USA Today and online platforms, the initiative debuts in today’s print and digital editions with educational content addressing common skin conditions, early detection, and routine care. The campaign officially launched nationwide in USA Today and online, as announced by Mediaplanet in a press release.
It arrives as melanoma diagnoses continue to climb nationwide.
An estimated 234,680 cases of melanoma will be diagnosed in the U.S. in 2026, according to the Skin Cancer Foundation, which cites data from the American Cancer Society. Of those, roughly 8,510 people are projected to die from the disease, with 5,500 men and 3,010 women. These figures reflect a 10.6% increase in new melanoma cases compared to prior projections.
In Texas, melanoma remains a significant concern, with the state ranking high in incidence; national breakdowns place Texas among the leading states for cases, though exact 2026 state-specific estimates align with broader trends showing elevated risk in southern regions due to higher UV exposure.
The campaign highlights prevention strategies in light of these statistics.
Experts emphasize daily sun protection as the most effective way to reduce risk, noting that more than 90% of cutaneous melanomas are linked to UV exposure.
New 2026 innovations in sun protection are featured prominently in the campaign materials. These include UV-sensing patches that change color to signal when reapplication is needed, hybrid formulas combining SPF with skincare benefits such as antioxidants and anti-aging ingredients, and lightweight, non-greasy textures designed for daily wear.
Discussions also center on the potential FDA approval of new broad-spectrum filters, such as bemotrizinol, proposed by the FDA in December 2025 for inclusion in the over-the-counter sunscreen monograph. If finalized, bemotrizinol could offer longer-lasting, broad-spectrum UVA/UVB protection with low skin absorption and minimal irritation, marking the first new active ingredient in decades.
The FDA’s proposal is detailed here, with ongoing review expected to influence products potentially by mid-to-late 2026.
Mediaplanet described the campaign as a coalition effort to advance skin health education and outcomes through evidence-based information. Organizers encourage readers to schedule annual skin checks and adopt consistent sun-protection habits, including broad-spectrum SPF 30 or higher, protective clothing, and shade-seeking during peak UV hours.
Additional details on national melanoma projections are available from the Skin Cancer Foundation here.
Texas-specific estimates come from Texas Oncology here.
